Without a doubt we are faced with greedy management in this company.
What matters is that we as shareholders are going to benefit despite the greediness.
I think perhaps their gathering up companies in a market with perceived tailwinds may benefit us, despite the management shortfall.
Ann: Creso Pharma Anticipates Increasing Q4 2021 Swiss Revenue, page-11
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)